Table 3 Perioperative data of the study population
n | Beta-Blockade (n = 37) | No Beta-Blockade (n = 69) | P-value | |
|---|---|---|---|---|
Total cumulative perioperative morphine equivalent dose (mg) | 106 | 230.9 (50.0–446.5) | 214.8 (44.3–431.5) | 0.9101 |
Duration of anesthesia (min) | 106 | 136 (91–231) | 124 (89–207) | 0.4801 |
Perioperative application of catecholamines | 106 | 33 (89.2%) | 56 (81.2%) | 0.2832 |
Perioperative application of antihypertensive medication | 106 | 7 (18.9%) | 8 (11.6%) | 0.3022 |
Atropin | 106 | 5 (13.5%) | 9 (13.0%) | 0.9462 |
Blood products | 106 | 2 (5.4%) | 2 (2.9%) | 0.5192 |
Incidence PONV | 106 | 8 (21.6%) | 10 (14.5%) | 0.3512 |
Incidence non- tolerable pain recovery room | 106 | 15 (40.5%) | 24 (34.8%) | 0.5582 |
Application of opioids | 106 | 21 (56.8%) | 31 (44.9%) | 0.2462 |
Total cumulative morphine equivalent dose recovery room (mg) | 106 | 2.1 (0–7.35) | 0 (0–7) | 0.3711 |
Recovery room length of stay (min) | 91 | 150 (96–207) | 116.5 (84–169.25) | 0.3421 |
Admission to ICU/PACU | 106 | 10 (27%) | 16 (23.2%) | 0.6612 |
Readmission to hospital within 30 days postoperative | 106 | 6 (16.2%) | 6 (8.7%) | 0.2442 |